BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12115559)

  • 1. Prognostic value of P53 mutations in rectal carcinoma.
    Rebischung C; Gérard JP; Gayet J; Thomas G; Hamelin R; Laurent-Puig P
    Int J Cancer; 2002 Jul; 100(2):131-5. PubMed ID: 12115559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients].
    Gérard JP; Chapet O; Morignat E; Romestaing P; Mornex F; Acharki A
    Ann Chir; 1999; 53(10):1003-10. PubMed ID: 10670149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?
    Chapet O; Romestaing P; Mornex F; Souquet JC; Favrel V; Ardiet JM; d'Hombres A; Gerard JP
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1371-7. PubMed ID: 15817339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
    Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
    Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
    Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma.
    Nehls O; Klump B; Holzmann K; Lammering G; Borchard F; Gruenagel HH; Gaco V; Gregor M; Porschen R
    Cancer; 1999 Jun; 85(12):2541-8. PubMed ID: 10375100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
    Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
    J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy.
    Wiggenraad R; Tamminga R; Blok P; Rouse R; Hermans J
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):29-35. PubMed ID: 9588914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis.
    Lopez-Crapez E; Bibeau F; Thézenas S; Ychou M; Simony-Lafontaine J; Thirion A; Azria D; Grenier J; Senesse P
    Br J Cancer; 2005 Jun; 92(12):2114-21. PubMed ID: 15956964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.
    Liang JT; Cheng YM; Chang KJ; Chien CT; Hsu HC
    Hepatogastroenterology; 1999; 46(26):830-7. PubMed ID: 10370622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.